Wedmont Private Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
Wedmont Private Capital's GILD Position: Q2 2026 in Review
Wedmont Private Capital reduced its Gilead Sciences (GILD) stake by 0.55% in Q2 2026, selling an estimated $23.6K and leaving 32,598 shares worth $4.23M. The position accounts for 0.12% of the portfolio, ranked #102.
Wedmont Private Capital first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.64M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Wedmont Private Capital held 32,598 shares of Gilead Sciences worth $4.23M as of Q2 2026.
- Wedmont Private Capital sold 179 Gilead Sciences shares in Q2 2026, an estimated $23.6K.
- Gilead Sciences made up 0.12% of Wedmont Private Capital's portfolio in Q2 2026, its #102 holding.
- Wedmont Private Capital first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
- Wedmont Private Capital's Gilead Sciences position peaked at $4.64M in Q1 2026.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.